Citadel Advisors’s Windtree Therapeutics Inc WINT Stock Holding History

Citadel Advisors’s Portfolio WINT Stock Details WINT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-13,100	Closed	-$15K	–	8547
2017 Q1	$15K	Buy	+13,100	New	+$17K	﹤0.01%	7319
2016 Q1	–	Sell	-1,543	Closed	-$5K	–	8835
2015 Q4	$5K	Buy	+1,543	New	+$6.33K	﹤0.01%	8468
2015 Q3	–	Sell	-1,293	Closed	-$12K	–	9487
2015 Q2	$12K	Sell	1,293 -43	-3%	-$604	﹤0.01%	8366
2015 Q1	$22K	Buy	1,336 +879	+192%	+$17.3K	﹤0.01%	7861
2014 Q4	$7K	Buy	457 +386	+544%	+$8.49K	﹤0.01%	8221
2014 Q3	$2K	Sell	71 -543	-88%	-$13.1K	﹤0.01%	8013
2014 Q2	$15K	Buy	614 +314	+105%	+$8.03K	﹤0.01%	7453
2014 Q1	$9K	Buy	+300	New	+$10.1K	﹤0.01%	7557

Other funds holding WINT

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

MPWT

MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

Citadel Advisors's WINT Position: Q1 2016 in Review

Citadel Advisors sold out of Windtree Therapeutics Inc (WINT) in Q1 2016, closing a stake of 9,091 shares — an estimated $27K sold.

Citadel Advisors first reported a position in WINT in Q4 2013 and held it in 8 quarters. The position peaked at $50K in Q1 2014. 34 funds tracked by Wall St. Rank hold WINT as of Q1 2016.

Citadel Advisors reported no remaining Windtree Therapeutics Inc position as of Q1 2016 after selling out during the quarter.
Citadel Advisors sold 9,091 Windtree Therapeutics Inc shares in Q1 2016, an estimated $27K.
Citadel Advisors first reported a position in Windtree Therapeutics Inc in Q4 2013 and held it in 8 quarters.
Citadel Advisors's Windtree Therapeutics Inc position peaked at $50K in Q1 2014.
34 funds tracked by Wall St. Rank held Windtree Therapeutics Inc as of Q1 2016.

Based on Citadel Advisors's 13F filing for Q1 2016, filed 13 May 2016.